Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the ...

Body weight and body mass index alone are not enough to predict whether someone will develop a metabolic disease. A new atlas of cells in fat tissue could help to explain why some overweight people ...

Time-restricted eating may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity.

In the U.S., the overall average body fat percentage is around 40% for women and 28% for men. Body fat (BF) percentage refers ...

(HealthDay News) — Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity, according to a ...

CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

Trends in early onset colorectal cancer–related mortality among adults in the United States from 1999-2020. Multi-site blinded validation of a deep learning approach for clinical-grade MSI/dMMR ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.